Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Status:
Terminated

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

This study is to estimate the efficacy of a number of doses in patients with pancreatic insufficiency

Phase 2

Solvay Pharmaceuticals